Form 8-K - Current report:
SEC Accession No. 0001193125-23-156575
Filing Date
2023-05-30
Accepted
2023-05-30 16:07:25
Documents
13
Period of Report
2023-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d473553d8k.htm   iXBRL 8-K 47979
2 EX-3.1 d473553dex31.htm EX-3.1 5297
  Complete submission text file 0001193125-23-156575.txt   175955

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20230525.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20230525_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20230525_pre.xml EX-101.PRE 10823
7 EXTRACTED XBRL INSTANCE DOCUMENT d473553d8k_htm.xml XML 3234
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 23976378
SIC: 2834 Pharmaceutical Preparations